1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for CFS here.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 18th March 2024 is here.
    Dismiss Notice
  3. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice

(Ongoing) Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis): An International Cross-Sectional Study (ME)

Discussion in 'Long Covid news' started by Dolphin, Dec 27, 2021.

  1. Dolphin

    Dolphin Senior Member (Voting Rights)

    Messages:
    4,987
    I did a few quick Googles and I'm not sure whether this study has started recruiting yet; I'm not fully confident that it ever will.

    From: Dr. Marc-Alexander Fluks


    Sourch: Clinical Trials
    U.S. National Library of Medicine
    Date: September 28, 2021
    URL: https://clinicaltrials.gov/ct2/show/NCT05059184


    Long-term Sequelae of COVID-19 (Myalgic Encephalomyelitis):
    An international cross-sectional study (ME)
    -----------------------------------------------------------

    Brief Summary

    The term recovery from COVID-19 caused by SARS-CoV-2 is unverified
    because the infection leaves many symptoms due to permanent effects on
    multiple organs; The primary objective of this research is to understand
    acute and chronic long COVID symptoms by asking questions detecting
    patient's experience especially symptoms lasting for several months
    which is known as chronic fatigue syndrome(Myalgic encephalitis). The
    study focuses on symptoms describing Myalgic encephalitis which may
    still affect COVID patients for several months after the infection along
    with making a big picture about rare symptoms that may the patient
    experienced during or after the infection.

    A secondary objective of this research is to focus on the long-term
    sequelae effects and comorbidities following COVID-19 vaccination.


    Detailed Description

    After the appearance of COVID-19 caused by SARS-CoV-2, the pandemic has
    spread and had a profound effect on the lives and health of people
    around the Whole world causing around 3.97 million deaths and more than
    183 million confirmed cases of the covid-19. The pandemic of COVID-19
    may leave unexplainable symptoms after recovery. COVID-19 pandemic has a
    lot of serious symptoms, but some last for some time even after the
    recovery. Even some of the people who had mild symptoms during COVID-19
    continue to have long terms effects after initial recovery. These people
    are called 'long haulers' and these symptoms are called Long COVID-19.
    Long haulers still suffer from permanent symptoms due to multi-organ
    dysfunction despite normal nucleic acid tests that detect the virus.

    According to Dr. Anthony Fauci 'patients with COVID-19 can develop a
    post-viral syndrome that's very strikingly similar to Myalgic
    encephalomyelitis/chronic fatigue syndrome' Long COVID-19 involves
    multiple organs and affects many systems mainly respiratory,
    cardiovascular, neurological, gastrointestinal, and musculoskeletal
    systems. The symptoms of long-covid include shortness of breath, cough,
    myalgias, disturbances in the sense of taste and smell, fatigue, fever,
    chills, and, less commonly, rhinitis and gastrointestinal symptoms
    cardiac abnormalities, cognitive impairment, sleep disturbances,
    symptoms of post-traumatic stress disorder, muscle pain, concentration
    problems, and headache. Those manifestations persist in one of 10
    patients of the infection and last for 3-4 weeks of acute symptoms and
    chronic symptoms last for more than 12 weeks after the infection.
    According to The Centers for Disease Control and Prevention (CDC), 150
    patients out of 300 who were PCR-positive for SARS-CoV-2 had permanent
    symptoms after three weeks after the positive test.

    In case the fatigue persists for six months, it is called Myalgic
    Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

    Although the period of 6 months is no longer required for ME diagnosis
    according to 2011's ME international Consensus Criteria, it is still
    common in literature.

    Chronic fatigue syndrome/post-viral myalgia can not only covid-19 but
    also follow viral infections such as Epstein-Barr virus, Ross River
    virus, enteroviruses, human herpesvirus, Ebola virus, West Nile virus,
    Dengue virus, and parvovirus; bacteria, such as Borrelia burgdorferi,
    Coxiella burnetii, and Mycoplasma pneumonia; and sometimes parasites,
    such as Giardia lamblia, so it is expected but the problem is that it is
    unknown how severe it is or how it can affect the public health.

    Recently, there has been global concern about the effectiveness and
    safety of COVID-19 vaccines. According to WHO, the most common side
    effects that were reported about COVID-19 vaccines were fever, fatigue,
    headache, muscle pain, chills, diarrhea, and pain at the injection site
    which is more or less like some of the post covid infection symptoms so
    it was found that it is logical to add a section to gather information
    about the vaccine status, type, and timing with the symptoms.

    Also, some cases were reported from Canada reported weird and rare
    symptoms like Beau lines.


    Study Design

    Study Type: Observational
    Estimated Enrollment: 20000 participants
    Observational Model: Other
    Time Perspective: Cross-Sectional
    Official Title: Long-term Sequelae of COVID-19 (Myalgic
    Encephalomyelitis): An International Cross-Sectional Study
    Actual Study Start Date: September 1, 2021
    Estimated Primary Completion Date: July 1, 2022
    Estimated Study Completion Date: September 1, 2022

    (...)


    Contacts and Locations

    Contacts
    Contact: Nour M Shaheen, Student 01060038774 nourshaheen40@gmail.com
    Contact: Ahmed M Shaheen, Student +20 101 099 1021
    ahmed.saad1704@alexmed.edu.eg

    Locations
    Alexandria Faculty of Medicine, Alexandria University, Alexandria,
    Egypt, 21523


    Study Documents

    Documents provided by Alexandria University: Study Protocol, September
    1, 2021,
    https://clinicaltrials.gov/ProvidedDocs/84/NCT05059184/Prot_000.pdf

    --------
    (c) 2021 U.S. National Library of Medicine
     
    Snow Leopard, Wonko, Samuel and 4 others like this.
  2. Samuel

    Samuel Senior Member (Voting Rights)

    Messages:
    620
    i [think i foggedly] get that they are just adding v stuff to the trial and i wouldn't question the reasons too much for observational trial but i'd still like to know what they are referring to anyway:

    > ecently, there has been global concern about the effectiveness and
    safety of COVID-19 vaccines. According to WHO, the most

    what concern by who? at pwme levels or the 1/100k normals levels?

    > common side
    effects that were reported about COVID-19 vaccines were fever, fatigue,
    headache, muscle pain, chills, diarrhea, and pain at the injection site

    how bad and long?

    > which is more or less like some of the post covid infection symptoms so
    it was found that it is logical to add a section to gather information
    about the vaccine status, type, and timing with the symptoms.
     
    Peter Trewhitt likes this.
  3. Simon M

    Simon M Senior Member (Voting Rights)

    Messages:
    882
    Location:
    UK
    Mithriel and Peter Trewhitt like this.
  4. Andy

    Andy Committee Member

    Messages:
    21,810
    Location:
    Hampshire, UK
    Merged thread

    Long-term sequelae of COVID-19 (myalgic encephalomyelitis): An international cross-sectional study 2022 Shaheen and Shaheen


    Abstract

    Background:
    As a result of prolonged effects on multiple organs, recovery from COVID-19 caused by SARS-CoV-2 cannot be verified. This study seeks to understand chronic and acute long-term symptoms of COVID-19 lasting from a few weeks after diagnosis. The study also aims to gain insight into prevalence of chronic fatigue syndrome/myalgic encephalomyelitis, a potentially comorbid condition for several months after the infection, in addition to taking a broad perspective on rare symptoms that may have developed during or after the infection.

    Study design:
    Cross-sectional questionnaire\descriptive study.

    Methods:
    The questionnaire was developed to assess the long-term effects of the global pandemic of COVID-19 using DePaul Symptom Questionnaire-2. The DePaul Symptom Questionnaire, Patient Health Questionnaire, and other symptoms that have been introduced by literature review.

    Discussion:
    A large cohort of people from all over the world will be examined to understand the differential effects of people who have experienced COVID-19, as well as the potential occurrence of ME. In total, 20,000 COVID patients are expected to be included in the study by Sep 1, 2022. Patients who have experienced COVID-19 will be asked about their persistent symptoms from 1 week up to more than 6 months after catching or recovery from the infection.

    Open access, https://journals.lww.com/md-journal...g_term_sequelae_of_COVID_19__myalgic.110.aspx
     
    Last edited by a moderator: Nov 25, 2022
  5. cassava7

    cassava7 Senior Member (Voting Rights)

    Messages:
    985
    This protocol does not make sense.

    The authors say that the study ran from September 2021 to September 2022, but they are only publishing the protocol now. Yet, they write:

    “The study will be conducted in centers or hospitals worldwide after getting the Institutional Review Board worldwide by the lead local investigator.”

    If the study was completed in September 2022, and given that the manuscript was sent to the journal on October 25th, ethical approvals for all the centers should already have been obtained. Yet only the following approvals are listed, without the relevant approval numbers from each ethics board:

    “Ethical approval was received from the Ethics committee of NewGiza university in November 2021(Approval No. N-14-2021) in Egypt, KRL Hospital Islamabad in Pakistan, University of Tobruk (UOT) in Libya, University of Aleppo in Syria and Hospital Riyadh Al-Jariri for fevers and treatment center for corona cases in Yemen.”

    Perhaps more puzzling is that only two investigators authored the paper while they mention that the study is being ran by 200 researchers in 28 countries:

    “This large-scale, international cross-sectional study is being conducted by ICRAA Team with collaboration with 200 researchers in 28 countries (India, Egypt, Pakistan, Brazil, Nigeria, Bangladesh, Algeria, UK, Perú, Lithuania, UAE, Jordan, Afghanistan, Yemen, Tunisia, Sudan, Turkey, Syria, Iraq, Kosovo, Morocco, Bahrain, Ecuador, Iran, United States, Palestine, Japan) around the world (Table 1).”
     
    cfsandmore and RedFox like this.
  6. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    2,199
  7. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    2,199
  8. Tom Kindlon

    Tom Kindlon Senior Member (Voting Rights)

    Messages:
    2,199
    He’s a medical student who is probably very busy studying. I wonder was it a project for the course? Though they usually need to be finished more quickly. Anyway a very ambitious project for a student to take on without funding, hopefully there will be something of value in it.
     
    RedFox likes this.

Share This Page